Neuromation: Neuromation Partner Insilico closed a strategic round of fundingneuromation machine-learning
This February we’ve announced a new partnership with Insilico. Today our friends and partners Insilico Medicine closed a strategic round of funding with four very strategic investors!
Neuromation CRO Sergey Nikolenko comments on the news:«I’m very happy that our long-term friends and partners Insilico Medicine have secured their next round of investments! We have been collaborating with Insilico for a long time, starting with joint work on drug discovery (see, e.g., this post), establishing a partnership with a blockchain-based project Longenesis led by Alex Zhavoronkov as well (see, e.g., this post) and now working together on an exciting project that brings together molecular biology an deep learning. This great news brings Insilico not only the money they need to expand their efforts to fight aging and discover new drugs with deep learning but also testing grounds at WuXi for the molecules they find. This will help Insilico bring their drugs to the market faster, and this is something we can all benefit from, not only as deep learning researchers but as human beings who want to live longer. I congratulate my dear friends, the CEO of Insilico Medicine Alex Zhavoronkov and CEO of Insilico Taiwan Artur Kadurin, and the rest of Insilico team alongside with whom I have had the pleasure to work.»
Neuromation Partner Insilico closed a strategic round of funding was originally published in Neuromation on Medium, where people are continuing the conversation by highlighting and responding to this story.
Original article was created by: Neuromation at medium.comDisclaimer: This article should not be taken as, and is not intended to provide, investment advice. Please conduct your own thorough research before investing in any cryptocurrency or ICO.
One more thing you may be interested in:
Interested in Cryptocurrencies and ICO's?
Follow our telegram channel for daily cryptomarket reports!Join @cointrends
|12 hours ago||machine-learning|
|2 days ago||machine-learning|
|3 days ago||neuromation|
|1 week ago||neuromation|
Stay on top of Altcoins and ICO trends.
Subscribe to our free Weekly Cryptomarket report
Delivered once a week, strongly to your inbox.Subscribe to our mailing list
June 19, 2018
Image sourceSince its inception, Neuromation has been working with creative professionals to find innovative use cases for artificial intelligence. Our goals are to improve the quality of work output while streamlining and simplifying the creative process across a range of use cases; and to use...From: Neuromation
June 13, 2018
The Neuromation Team is always open to dialogue with our community members and strives towards a transparent business. Last week, Neuromation Chairman Constantine Goltsev and President of Digital Economy Maxim Prasolov joined our Japanese Telegram chat for an AMA session to answer your...From: Neuromation
June 11, 2018
Pediatric Bone Age AssesmentHealthcare is one of the most exciting areas of artificial intelligence research, and is currently ongoing at some of the largest companies in the world, including Intel, IBM, Google and Apple. There are also numerous well-funded start-ups in the space, including...From: Neuromation
June 06, 2018
We have great news: we’ve got not one, not two, but three papers accepted to the DeepGlobe workshop at the top computer vision conference, CVPR 2018! This is a big result for us: it shows that our team is able to compete with the very best and get to the main conferences in our field.Today,...From: Neuromation
May 24, 2018
Today we continue the NeuroNuggets series with a new installment. This is the first time when a post written by one of our deep learning researchers was so long that we had to break it up into two parts. In the first part, we discussed the notion of a computational graph and what functionality...From: Neuromation